We are live on ! Find out more
NCM

NovaQuest Capital Management Portfolio holdings

AUM $54.3M
1-Year Est. Return 163.39%
This Fund
S&P 500
This Quarter Est. Return
+24.02%
1 Year Est. Return
+163.39%
3 Year Est. Return
+45.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
–
Cap. Flow
+$105M
Cap. Flow %
83.41%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$88.9M
2
MYOV
Myovant Sciences Ltd.
MYOV
+$15.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVNC
1
DELISTED
Revance Therapeutics, Inc.
RVNC
$111M 88.05%
+3,096,650
New +$88.9M
MYOV
2
DELISTED
Myovant Sciences Ltd.
MYOV
$15M 11.95%
+1,188,361
New +$15.9M

Similar funds

SCM
Stumpf Capital Management Scottsdale, Arizona $53.8M AUM 43.02% 1-Year Est. Return
RMCP
Red Mountain Capital Partners Los Angeles, California $55.4M AUM 35.53% 1-Year Est. Return
OQC
Optimum Quantvest Corp Stamford, Connecticut $51.8M AUM 10.08% 1-Year Est. Return
FTIM
Flowering Tree Investment Management Singapore $57.2M AUM 50.6% 1-Year Est. Return
OAM
Orinda Asset Management Lafayette, California $48.7M AUM 26.85% 1-Year Est. Return
FVP
Firefly Value Partners Newtown, Pennsylvania $59.9M AUM 5.97% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
SBA
Secrest Blakey & Associates Raleigh, North Carolina $43.7M AUM 1.11% 1-Year Est. Return

NovaQuest Capital Management's Q4 2017 Portfolio in Review

Q4 2017 is the first quarter with a 13F filing on record for NovaQuest Capital Management, which disclosed 2 positions worth $126M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Revance Therapeutics, Inc.: 3,096,650 shares worth $111M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • NovaQuest Capital Management's largest Q4 2017 buy was Revance Therapeutics, Inc.: 3,096,650 shares worth $111M.
  • NovaQuest Capital Management's ten largest holdings make up 100% of its $126M portfolio in Q4 2017.
  • NovaQuest Capital Management disclosed 2 positions in Q4 2017, its first 13F filing on record.

Based on NovaQuest Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.